ECLIA; Surface Plasmon Resonance
Clinically Reportable Ranges:
Certolizumab: Results of 1 ug/mL or higher indicate detection of certolizumab
Anti-Certolizumab antibody: Results of 40 ng/mL or higher indicate detection of anti-certolizumab pegol antibodies
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
3 - 6 days
Test sent to Mayo Medical Laboratories; performed by Esoterix